This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Wyeth. Active years: 2008-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2011
Title: Biography of Elizabeth Ann Gleason
Introduction: Elizabeth Ann Gleason is an accomplished inventor based in Rocky River, Ohio. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. With a total of five patents to her name, her work has the potential to impact the treatment of various disorders.
Latest Patents: Among her latest patents are two notable inventions. The first is titled "Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof." This invention relates to indole acetic acid compounds that function as antagonists of the CRTH2 receptor. It also discusses the use of these compounds to inhibit the binding of prostaglandin D and its metabolites, as well as certain thromboxane metabolites to the CRTH2 receptor, aiming to treat disorders responsive to such inhibition. The second patent is "Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof." This invention focuses on benzimidazole acetic acid compounds that act as antagonists of the CRTH2 receptor, with similar therapeutic applications.
Career Highlights: Elizabeth works at Wyeth, a prominent pharmaceutical company known for its innovative research and development. Her role involves the exploration and creation of new therapeutic compounds that can lead to advancements in medical treatments.
Collaborations: Throughout her career, Elizabeth has collaborated with
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile